MarketCap
Facebook
X
Telegram
Assertio Holdings DIO Ratio | ASRT
Annual DIO Ratio Assertio Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 322 | 354 | 347 | 206 | 221 | 215 | 131 | 67.1 | 65.6 | 54.4 | 56.4 | 204 | 522 | 579 | 355 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 579 | 54.4 | 247 |
Quarterly DIO Ratio Assertio Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 804 | 193 | 309 | 455 | - | 477 | 399 | 311 | - | 398 | 335 | 250 | - | 302 | 219 | 185 | - | 181 | 181 | 237 | - | 165 | 204 | 493 | - | 139 | 73.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 804 | 73.3 | 300 |
DIO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B |  USA |
 |
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M |  Irlanda |
 |
OptiNose
OPTN
|
493 | - | - | $ 1.08 B | USA |
 |
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | USA |
 |
Canopy Growth Corporation
CGC
|
176 | $ 0.65 | -3.6 % | $ 194 M |  Canada |
 |
Aurora Cannabis
ACB
|
1.35 K | $ 5.24 | 0.87 % | $ 287 M | Canada |
 |
Harrow Health
HROW
|
65.1 | $ 26.86 | 3.15 % | $ 987 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
280 | $ 5.26 | 4.99 % | $ 78.1 M | USA |
 |
Emergent BioSolutions
EBS
|
367 | $ 6.04 | 3.25 % | $ 323 M | USA |
 |
Cronos Group
CRON
|
523 | $ 3.62 | -2.82 % | $ 1.39 B | Canada |
 |
Evolus
EOLS
|
71.3 | $ 6.86 | 0.88 % | $ 442 M | USA |
 |
Bausch Health Companies
BHC
|
172 | $ 8.19 | 2.7 % | $ 3.04 B | Canada |
 |
OrganiGram Holdings
OGI
|
2.83 K | $ 0.88 | -5.39 % | $ 83.9 M | Canada |
 |
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
98.9 | $ 1.12 | 5.1 % | $ 1.89 M | USA |
 |
TherapeuticsMD
TXMD
|
1.04 K | $ 1.7 | -0.58 % | $ 19.7 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
30.8 | - | 7.5 % | $ 6.35 M | USA |
 |
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | USA |
 |
ProPhase Labs
PRPH
|
74.8 | - | - | $ 5.07 M | USA |
 |
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | USA |
 |
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B |  France |
 |
Organogenesis Holdings
ORGO
|
85.9 | $ 0.84 | 0.19 % | $ 106 M | USA |
 |
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | USA |
 |
Pacira BioSciences
PCRX
|
339 | $ 36.43 | 0.03 % | $ 1.62 B | USA |
 |
Perrigo Company plc
PRGO
|
148 | $ 15.83 | 0.83 % | $ 2.19 B | USA |
 |
Rockwell Medical
RMTI
|
29.2 | $ 7.76 | 2.04 % | $ 279 M | USA |
 |
Tilray
TLRY
|
159 | $ 2.91 | 3.56 % | $ 325 M | Canada |
 |
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | USA |
 |
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | USA |
 |
Veru
VERU
|
179 | $ 2.14 | 3.88 % | $ 31.3 M | USA |
 |
Viatris
VTRS
|
154 | $ 19.72 | 5.03 % | $ 22.9 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | USA |
 |
cbdMD
YCBD
|
138 | $ 0.42 | 6.96 % | $ 1.69 M | USA |
 |
China Pharma Holdings
CPHI
|
166 | $ 0.57 | 8.66 % | $ 2.45 M |  China |
 |
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | USA |
 |
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | USA |
 |
DURECT Corporation
DRRX
|
557 | - | - | $ 50.1 M | USA |
 |
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | USA |